130 related articles for article (PubMed ID: 33408297)
21. Establishment and characterization of a mouse model of rhabdomyolysis by coadministration of statin and fibrate.
Watanabe K; Oda S; Matsubara A; Akai S; Yokoi T
Toxicol Lett; 2019 Jun; 307():49-58. PubMed ID: 30853469
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy and safety of combined statin-fenofibrates therapy compared with monotherapy in patients with mixed hyperlipidemia and high risk of coronary heart disease].
Kłosiewicz-Latoszek L; Respondek W; Białobrzeska-Paluszkiewicz J; Grzybowska B; Jakóbisiak-Ostasz B; Stolarska I
Pol Merkur Lekarski; 2003 Jul; 15(85):42-6. PubMed ID: 14593958
[TBL] [Abstract][Full Text] [Related]
23. β-Sitosterol Attenuates Dexamethasone-Induced Muscle Atrophy via Regulating FoxO1-Dependent Signaling in C2C12 Cell and Mice Model.
Hah YS; Lee WK; Lee S; Kim EJ; Lee JH; Lee SJ; Ji YH; Kim SG; Lee HH; Hong SY; Yoo JI
Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889851
[TBL] [Abstract][Full Text] [Related]
24. Aging- and obesity-related peri-muscular adipose tissue accelerates muscle atrophy.
Zhu S; Tian Z; Torigoe D; Zhao J; Xie P; Sugizaki T; Sato M; Horiguchi H; Terada K; Kadomatsu T; Miyata K; Oike Y
PLoS One; 2019; 14(8):e0221366. PubMed ID: 31442231
[TBL] [Abstract][Full Text] [Related]
25. Analysis of a Skeletal Muscle Injury and Drug Interactions in Lovastatin- and Fenofibrate-Coadministered Dogs.
Kawata R; Yokoi T
Int J Toxicol; 2019; 38(3):192-201. PubMed ID: 31113311
[TBL] [Abstract][Full Text] [Related]
26. Hydrogen sulfide alleviates hyperhomocysteinemia-mediated skeletal muscle atrophy via mitigation of oxidative and endoplasmic reticulum stress injury.
Majumder A; Singh M; Behera J; Theilen NT; George AK; Tyagi N; Metreveli N; Tyagi SC
Am J Physiol Cell Physiol; 2018 Nov; 315(5):C609-C622. PubMed ID: 30110564
[TBL] [Abstract][Full Text] [Related]
27. Rhabdomyolysis and acute renal failure induced by combination lovastatin and gemfibrozil therapy.
Marais GE; Larson KK
Ann Intern Med; 1990 Feb; 112(3):228-30. PubMed ID: 2297197
[No Abstract] [Full Text] [Related]
28. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
[TBL] [Abstract][Full Text] [Related]
29. The cathepsin L gene is a direct target of FOXO1 in skeletal muscle.
Yamazaki Y; Kamei Y; Sugita S; Akaike F; Kanai S; Miura S; Hirata Y; Troen BR; Kitamura T; Nishino I; Suganami T; Ezaki O; Ogawa Y
Biochem J; 2010 Mar; 427(1):171-8. PubMed ID: 20088826
[TBL] [Abstract][Full Text] [Related]
30. PPARα agonist fenofibrate relieves acquired resistance to gefitinib in non-small cell lung cancer by promoting apoptosis via PPARα/AMPK/AKT/FoxO1 pathway.
Wang MS; Han QS; Jia ZR; Chen CS; Qiao C; Liu QQ; Zhang YM; Wang KW; Wang J; Xiao K; Ding XS
Acta Pharmacol Sin; 2022 Jan; 43(1):167-176. PubMed ID: 33772142
[TBL] [Abstract][Full Text] [Related]
31. Case of the month: February 1999--54 year old man with severe muscle weakness.
Hill MD; Bilbao JM
Brain Pathol; 1999 Jul; 9(3):607-8. PubMed ID: 10416996
[TBL] [Abstract][Full Text] [Related]
32. Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism.
Smith IJ; Alamdari N; O'Neal P; Gonnella P; Aversa Z; Hasselgren PO
Int J Biochem Cell Biol; 2010 May; 42(5):701-11. PubMed ID: 20079455
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.
Reed SA; Sandesara PB; Senf SM; Judge AR
FASEB J; 2012 Mar; 26(3):987-1000. PubMed ID: 22102632
[TBL] [Abstract][Full Text] [Related]
34. A short-term statin treatment changes the contractile properties of fast-twitch skeletal muscles.
Piette AB; Dufresne SS; Frenette J
BMC Musculoskelet Disord; 2016 Oct; 17(1):449. PubMed ID: 27793139
[TBL] [Abstract][Full Text] [Related]
35. Imoxin attenuates LPS-induced inflammation and MuRF1 expression in mouse skeletal muscle.
Valentine RJ; Jefferson MA; Kohut ML; Eo H
Physiol Rep; 2018 Dec; 6(23):e13941. PubMed ID: 30548229
[TBL] [Abstract][Full Text] [Related]
36. Sestrin prevents atrophy of disused and aging muscles by integrating anabolic and catabolic signals.
Segalés J; Perdiguero E; Serrano AL; Sousa-Victor P; Ortet L; Jardí M; Budanov AV; Garcia-Prat L; Sandri M; Thomson DM; Karin M; Hee Lee J; Muñoz-Cánoves P
Nat Commun; 2020 Jan; 11(1):189. PubMed ID: 31929511
[TBL] [Abstract][Full Text] [Related]
37. Skeletal muscle-specific forkhead box protein-O1 overexpression suppresses atherosclerosis progression in apolipoprotein E-knockout mice.
Shimba Y; Senda R; Katayama K; Morita A; Ikeda M; Kamei Y; Miura S
Biochem Biophys Res Commun; 2021 Feb; 540():61-66. PubMed ID: 33450481
[TBL] [Abstract][Full Text] [Related]
38. The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene.
Waddell DS; Baehr LM; van den Brandt J; Johnsen SA; Reichardt HM; Furlow JD; Bodine SC
Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E785-97. PubMed ID: 18612045
[TBL] [Abstract][Full Text] [Related]
39. Regulation of glucose uptake and inflammation markers by FOXO1 and FOXO3 in skeletal muscle.
Lundell LS; Massart J; Altıntaş A; Krook A; Zierath JR
Mol Metab; 2019 Feb; 20():79-88. PubMed ID: 30502001
[TBL] [Abstract][Full Text] [Related]
40. Aspartate inhibits LPS-induced MAFbx and MuRF1 expression in skeletal muscle in weaned pigs by regulating Akt, AMPKα and FOXO1.
Liu Y; Wang X; Leng W; Pi D; Tu Z; Zhu H; Shi H; Li S; Hou Y; Hu CA
Innate Immun; 2017 Jan; 23(1):34-43. PubMed ID: 28064564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
